|OncoSec Medical Incorporated|
9810 Summers Ridge Road
United States - Map
OncoSec Medical Incorporated, a hybrid device and gene therapy biotechnology company, designs, develops, and commercializes medical approaches principally immunotherapy for the treatment of solid tumors in the United States. Its clinical programs include three Phase II clinical trials to assess the ImmunoPulse technology in patients with melanoma, Merkel cell carcinoma, and cutaneous T-cell lymphoma. It has a collaboration agreement with Heat Biologics, Inc. to evaluate the combination of immunotherapy platforms. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated is headquartered in San Diego, California.
|Dr. Avtar S. Dhillon M.D.,
Co-Founder, Chairman, Chairman of Financing Committee, Chairman of Compensation Committee, Member of Nominating & Corp. Governance Committee, Member of Clinical & Regulatory Affairs Committee and Member of Audit Committee
|Mr. Punit S. Dhillon ,
Co-Founder, Chief Exec. Officer, Pres and Director
|Ms. Veronica Vallejo CPA,
Chief Financial Officer, Principal Accounting Officer and VP of Fin.
|Dr. Robert Hamilton Pierce M.D.,
Chief Scientific Officer and Global Head of R&D
|Mr. Tu Diep M.Sc.,
VP of Operations
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|